Literature DB >> 26886414

TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.

Kazuya Sakai1, Takeshi Maeda1, Akira Kuriyama2, Noriaki Shimada3, Kenji Notohara4, Yasunori Ueda1.   

Abstract

Thrombocytopenia, anasarca, fever, reticulin fibrosis, and organomegaly (TAFRO) syndrome is considered as a unique clinicopathologic variant of multicentric Castleman's disease and is recently reported in Japan. This entity represents a severe inflammatory state leading to organ failures such as severe liver dysfunction seen in our case, and can be treated by immunosuppressive agents, steroids, and cyclosporine shown in several case reports. A systematic review and our case suggest the potential utility of tocilizumab as a treatment for TAFRO syndrome.

Entities:  

Keywords:  Castleman’s disease; Liver injury; Systematic review; Thrombocytopenia; Tocilizumab; anasarca; and organomegaly syndrome; fever; reticulin fibrosis

Mesh：

Substances：

Year:  2016        PMID： 26886414     DOI： 10.3109/14397595.2015.1120389

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN： 1439-7595            Impact factor:   3.023


  15 in total

1.  Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.

Authors:  Hirotaka Saito; Kenichi Tanaka; Momoko Fujiwara; Tsuyoshi Iwasaki; Tokutaro Numata; Akira Oda; Makoto Kanno; Mizuko Tanaka; Masaaki Eiro; Mamoru Satoh; Junichiro James Kazama
Journal:  CEN Case Rep       Date:  2019-05-10

2.  Liver cirrhosis in a child associated with Castleman's disease: A case report.

Authors:  Soya Kobayashi; Ayano Inui; Tomoyuki Tsunoda; Syuichiro Umetsu; Tsuyoshi Sogo; Masaaki Mori; Masato Shinkai; Tomoo Fujisawa
Journal:  World J Clin Cases       Date:  2020-05-06       Impact factor: 1.337

3.  Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

Authors:  David C Fajgenbaum; David Wu; Aaron Goodman; Raymond Wong; Amy Chadburn; Sunita Nasta; Gordan Srkalovic; Sudipto Mukherjee; Heather Leitch; Raj Jayanthan; Simone Ferrero; Yasuharu Sato; Steve Schey; Angela Dispenzieri; Eric Oksenhendler; Pier Luigi Zinzani; Mary Jo Lechowicz; Christian Hoffmann; Naveen Pemmaraju; Adam Bagg; Alexander Fossa; Megan S Lim; Frits van Rhee
Journal:  Am J Hematol       Date:  2020-09-25       Impact factor: 13.265

4.  Tocilizumab-induced immunocomplex glomerulonephritis: a report of two cases.

Authors:  Daichi Fukaya; Tsutomu Inoue; Yuta Kogure; Hiroshi Kajiyama; Keisuke Ishizawa; Takeru Seto; Hajime Hasegawa; Toshihide Mimura; Hirokazu Okada
Journal:  CEN Case Rep       Date:  2020-04-27

5.  Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease.

Authors:  Alvaro Ortiz; Pedro Cárdenas; Marcela Peralta; Harold Rodríguez; Gabriel Frederick; Jacobo Ortiz
Journal:  Int Ophthalmol       Date:  2017-07-27       Impact factor: 2.029

6.  Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging.

Authors:  Mizuho Nara; Atsushi Komatsuda; Fumiko Itoh; Hajime Kaga; Masaya Saitoh; Masaru Togashi; Yoshihiro Kameoka; Hideki Wakui; Naoto Takahashi
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

7.  TAFRO Syndrome with Disseminated Intravascular Coagulation Successfully Treated with Tocilizumab and Recombinant Thrombomodulin.

Authors:  Yusuke Takayama; Tetsuya Kubota; Yoshitaka Ogino; Hiroshi Ohnishi; Kazuto Togitani; Akihito Yokoyama
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

8.  Fatal case of TAFRO syndrome with unilateral adrenal hemorrhage in early-stage disease.

Authors:  Tomoya Okamoto; Shinichi Ochi; Yuki Motokawa; Hidekazu Azumi; Shinya Kobayashi; Fumihiko Nakamura; Toshiya Nakatani; Hideo Yagi
Journal:  J Clin Exp Hematop       Date:  2021

9.  Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.

Authors:  Tatsuya Aoki; Mikio Wada; Atsushi Kawashima; Kouichi Hirakawa; Akihiro Nagata; Keizo Kagawa
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

Review 10.  Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.

Authors:  Mari Tanaka; Hiraku Tsujimoto; Kojiro Yamamoto; Saeko Shimoda; Kazumasa Oka; Hiroya Takeoka
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.